Showing results (71-80 of 139) with videos related to
Sort By:
Pageof 14
Cell Discovery|January 1, 2025
The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct immune responses against pathogen to target solid tumorsRenhao Li, Jing-Chu Hu, Li Rong, et al.Liver Cancer|August 20, 2021
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 StudyShukui Qin, Zhenggang Ren, Yin-Hsun Feng, et al.Liver Cancer|July 9, 2021
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 TrialMasatoshi Kudo, Ho Yeong Lim, Ann-Lii Cheng, et al.Journal of Gastroenterology and Hepatology|March 3, 2021
Programmed cell death-ligand 1 expression in hepatocellular carcinoma and its correlation with clinicopathological characteristicsHaibo Mou, Qiu-An Yang, Lanfang Yu, et al.Journal for Immunotherapy of Cancer|February 10, 2021
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitorsJeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Vikki Tang, et al.Frontiers in Immunology|April 11, 2022
Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough VariantsYe-Fan Hu, Jing-Chu Hu, Hua-Rui Gong, et al.Advances in Therapy|June 1, 2021
The Outcomes of Systemic Treatment in Recurrent Hepatocellular Carcinomas Following Liver TransplantsBryan Cho Wing Li, Joanne Chiu, Kit Shing, et al.JHEP Reports : Innovation in Hepatology|April 15, 2024
A phase Ib/II trial of capmatinib plus spartalizumab <i>vs.</i> spartalizumab alone in patients with pretreated hepatocellular carcinomaArmando Santoro, Eric Assenat, Thomas Yau, et al.Liver Cancer|May 29, 2026
Efficacy of Nivolumab plus Ipilimumab in Advanced Hepatocellular Carcinoma with and without High-Risk Features: An International Multicenter StudyJung Sun Kim, San-Chi Chen, Jeffrey Sum Lung Wong, et al.Thescientificworldjournal|February 15, 2014
Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastasesTan To Cheung, Kenneth S H Chok, Albert C Y Chan, et al.Pageof 14